Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access ...

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

People with chronic kidney disease and type 2 diabetes may face heart disease up to 28 years earlier than others.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

A landmark genetic study published in the New England Journal of Medicine has identified a significant genetic factor ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

People with chronic kidney disease (CKD), Type 2 diabetes, or both were predicted to have elevated cardiovascular disease ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...